Equisetum arvense

Quick links

Choose a section

Quick links to important sections

Advertisements

Equisetum arvense

Selected form

Advertisements
Advertisements

Overview of Equisetum arvense

Property Description
Active ingredient Herbal substance (Dried green sterile stems of E. arvense L.)
Form Capsules, tablets, tinctures, dried herb for infusion
Pharmacological class Phytotherapeutic drug, Diuretic
Common use Supporting urinary tract function and tissue integrity
Origin Natural, Perennial herb native to the Northern Hemisphere

What Type of Medicine is Equisetum arvense?

Equisetum arvense, known commonly as Horsetail, is an established phytotherapeutic drug and herbal medicine derived from the dried green sterile stems of the perennial, spore-bearing plant. The product is strictly plant-derived and utilized within traditional medicine systems across various regions. Equiseti herba is recognized for its long-standing traditional use, distinguishing it from newer, synthetic compounds. This classification means the substance has a plausible, established history of application focused on general system wellness.

What is the Composition and Primary Action of Horsetail?

The identity of Horsetail is characterized by its unique chemical composition, primarily its high content of silicic acid (silica), various flavonoids, and mineral salts. The high silica content is a differentiating compositional feature that provides the foundational support thought to enhance the integrity of connective tissues. Pharmacological studies have supported the primary physiological effect, which establishes its classification as a gentle diuretic, promoting the body’s fluid balance by increasing the production of urine. The overall benefit is derived from this dual action: an observed natural flushing effect and the silica-based support for skin and skeletal structures.

What Forms and Preparations of E. arvense Are Available?

Horsetail is widely available for oral administration in multiple standardized dosage forms, including concentrated capsules, tablets, liquid extracts, and the dried herbal substance used to prepare traditional infusions or decoctions. A distinguishing manufacturing difference is that the extracts are often standardized to ensure consistent levels of silicic acid across batches. These forms vary in their base—ranging from aqueous bases for teas to alcohol-based solvents for tinctures—but all serve as mechanisms to deliver the plant’s key active components.

Advertisements

What side effects are possible with Equisetum arvense?

Possible Side Effects and Safety Information

Regulatory assessments of Equisetum arvense (Horsetail) establish a safety profile based on its physiological action and documented case reports. The official safety documentation explicitly defines restrictions on use and outlines the types of adverse reactions that have been reported.

Documented Adverse Reactions and Frequency

Formal frequency classifications (e.g., Common, Uncommon) are generally not assigned in primary regulatory monographs. Safety reports categorize observed effects descriptively:

  • Minor side effects are associated with the Gastrointestinal System, including abdominal discomfort and nausea.
  • Rare instances describe Hypersensitivity Reactions (such as skin rash or allergic dermatitis) and effects on the Hepatobiliary System, including rare reports of elevated liver enzymes or liver injury.

Safety Restrictions and Special Populations

Official regulatory documents define absolute contraindications and specific limitations for certain conditions and populations:

  • Contraindications: Use is restricted for individuals with severe cardiac diseases or severe renal diseases, as these are conditions where the body requires reduced fluid intake. It is also contraindicated in cases of known hypersensitivity to the active substance.
  • Vulnerable Populations: The medicine is not recommended for use in children under 12 years of age or by women who are pregnant or breastfeeding, due to insufficient safety data. Use of high doses given long term is specifically discouraged for individuals with preexisting liver disease or cirrhosis.
  • Signs of Complication: Regulatory warnings list symptoms such as fever, painful urination (dysuria), spasm, or blood in urine as signs of complications that must be observed.

The official safety structure, which notes that no interactions are reported with other medicinal products, clearly establishes boundaries for use that align with the substance's primary action as a diuretic.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory profile for the overdose of Equisetum arvense (Horsetail herb) is clearly defined by the official records maintained by government health authorities, such as the European Medicines Agency (EMA).

Official Overdose Status

Classification Status in Regulatory Documentation
Documented Overdose Cases None reported. The official regulatory record for this herbal substance does not contain reports of overdose (EMA).
Documented Manifestations None. As no overdose cases are reported, no specific symptoms, clinical signs, or severe outcomes are formally listed in the official labeling.
Antidote or Treatment None. Due to the absence of reported cases, no specific antidote, gastric lavage, or other mandatory procedural steps for overdose management are defined in regulatory documents.

When to Seek Urgent Medical Help

While specific overdose instructions are absent, regulatory labeling provides explicit guidance on when to consult a healthcare practitioner during the use of Equisetum arvense:

  • Worsening Symptoms: A doctor or qualified health care practitioner must be consulted if complaints or symptoms such as fever, dysuria (painful urination), spasm, or blood in the urine occur, or if the symptoms worsen.
  • Symptom Persistence: Medical advice is required if general symptoms persist longer than one week.
Advertisements

Therapeutic Uses of Equisetum arvense

What Equisetum arvense Treats: Main Uses and Benefits

The use of Horsetail is traditionally applied across domains involving systemic and structural maintenance. It is relevant in clinical contexts involving minor urinary complaints, symptoms related to non-complicated fluid retention (edema), and structural weakness of the body’s tissues.


Therapeutic Support and Benefits

Equisetum arvense is commonly used to help manage symptomatic discomfort across two main areas: urinary tract function and connective tissue integrity. It provides support that helps ease the overall symptom burden by supporting the body's natural fluid clearance, which may assist with managing inconvenience associated with symptoms that interfere with daily functioning, such as minor urinary frequency or nocturia. Additionally, it contributes to improved comfort by supporting the structural quality and resilience of connective tissues, including bone, ligaments, and the integumentary system.

“It is commonly used when symptoms create noticeable physiological strain and when supportive symptom management for structural integrity is required.”

Common indications for which it is applied include minor urinary tract discomfort, non-complicated swelling due to fluid accumulation, and the fragility of hair and nails.


Quick Fact: Support for Structural Weakness

Equisetum arvense is commonly used to help with brittle nail syndrome and to offer support during recovery from minor physical strain, assisting with maintaining functional stability in these contexts.

Advertisements

Eligibility and Restrictions for Use

The eligibility profile for Equisetum arvense is governed by official regulatory standards, which establish clear restrictions and contraindications for specific populations. Use is officially established and permitted for adults, adolescents from 12 years of age, and the elderly. Eligibility for all other groups is restricted or prohibited as defined by government labeling, often due to the product's diuretic effect or lack of established safety data.

Officially Documented Eligibility Restrictions

Eligibility Classification Population Group or Condition
Contraindicated Known hypersensitivity to the substance
Contraindicated Severe cardiac disease
Contraindicated Severe renal disease
Contraindicated Conditions requiring a reduced fluid intake
Not Recommended Children under 12 years of age (Use not established)
Not Recommended Pregnant or lactating individuals (Insufficient data)

The medicine is absolutely contraindicated for any patient with severe cardiac or renal disease, specifically where a medical need exists to restrict fluid intake. For both pediatric use under 12 and during pregnancy and lactation, use is formally not recommended by regulatory bodies, a classification based on the absence of sufficient data to confirm safety in these groups.

Advertisements

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Equisetum arvense

Category Official Regulatory Information
Medicinal product categories with documented interactions: Diuretic drugs; Antidiabetes drugs; Antiretroviral drugs.
Specific interacting medicines (if explicitly listed): Lithium; Ethanol (Alcohol); Efavirenz (documented in case reports).
Mechanistic basis of interactions (only if stated in label): Pharmacodynamic interaction (additive effects); Exposure modification via reduced clearance (for Lithium); Substance interaction (Thiaminase content impacting Thiamine status).
Timing-based interaction rules (if applicable): None officially specified in government regulatory labeling.
Population-specific interaction notes (if applicable): Individuals with severe cardiac disease or severe renal disease; Populations with a high risk of Thiamine deficiency.
Interaction-related restrictions: Use is contraindicated in patients with conditions where reduced fluid intake is officially recommended.

Interaction classifications (high-level)

Classification Type Official Regulatory Statement
Interaction severity classification (as defined in official documents): Classified as a Contraindication in specific disease states; Listed as Use with Caution / Potential Risk for co-administration with specific drugs.
Regulatory basis (EMA / FDA / etc.): EMA Monograph (Traditional Use, Contraindications); NIH MedlinePlus (Drug Interactions data).
Interaction-context constraints (as defined in official documents): The diuretic effect necessitates restriction of use in patients with fluid balance concerns. The thiaminase content restricts use in patients with Thiamine deficiency risk.

Resulting interaction structure

The regulatory interaction profile for Equisetum arvense is defined by the consequences of its two primary attributes: its diuretic activity and its thiaminase content. The diuretic action necessitates an interaction-related restriction in patients with severe cardiac or renal disease and underlies the pharmacodynamic risk with other diuretic medications, as well as the exposure modification risk with Lithium. The thiaminase content contributes the remaining official risk profile, specifically the substance interaction concerning Thiamine status.

Advertisements

Mechanism of Action

Renal Fluid and Electrolyte Modulation

This primary mechanism is driven by the plant’s flavonoids and mineral salts acting on renal tubule cells to promote the elimination of water and solutes. This action affects fluid homeostasis by increasing the volume of urine produced, a mild process characterized as an aquaretic effect.

Connective Tissue Matrix Stabilization

The unique presence of silicic acid is central to this domain, acting as a critical cofactor necessary for enzymes that build and cross-link collagen and elastin fibers. This stabilizes the structural integrity and mechanical properties of tissues, including those in the bone and skin, a process which is rate-limited by natural cellular synthesis cycles.

Antioxidant and Complementary Modulation

The rich profile of flavonoids provides an antioxidant activity through free radical scavenging of Reactive Oxygen Species (ROS), reducing the impact of oxidative stress on cellular components and the structural matrix. This antioxidant mechanism works in a complementary manner with the silicic acid mechanism, contributing to the stability and mechanical properties of connective tissues.

Advertisements

Dosage and Administration Information

How to Use Equisetum arvense (Horsetail)

The administration of Equisetum arvense is defined by established parameters for its traditional use as a supportive agent. These instructions govern the routes, dosing, and duration for its preparation, focusing on standardized delivery of the herbal substance.


Official Administration Guidelines

Instruction Entity Regulatory Standard
Route(s) of Administration Primarily Oral (internal use). Also approved for Cutaneous/Topical use (external application).
Standard Oral Daily Dose 3 to 12 grams of the comminuted herbal substance.
Dosing Frequency The total daily dose is typically divided and taken 3 to 4 times daily.
Course Duration Limit Recommended for short-term use, generally limited to 2 to 4 weeks.

Preparation and Usage Rules

Standardized instructions involve specific steps for proper intake, particularly when using the dried herb for tea. This ensures consistency with traditional preparation methods and addresses its intended diuretic action.

  • Herbal Tea Preparation: A single dose (e.g., 1 to 4 g) of the comminuted herb is to be prepared as an infusion or decoction in approximately 150 mL of boiling water.
  • Fluid Intake: When using solid forms (capsules, tablets) or liquid extracts, appropriate fluid intake must be ensured throughout the treatment period to support the medicine's function.
  • Age Restriction: Guidelines do not recommend the use of Equisetum arvense preparations in children under 12 years of age due to insufficient data.
  • Consultation Constraint: If symptoms persist or worsen after 1 week of use, the medicine's instruction requires consultation with a qualified healthcare practitioner, limiting prolonged self-administration.
Advertisements

Recent Clinical Evidence

Equisetum arvense: Recent Clinical Evidence

Recent clinical research on Equisetum arvense (field horsetail) has primarily investigated its traditional uses, focusing on its potential diuretic and bone health effects. These studies have helped to establish a preliminary evidence base, though large-scale trials remain limited.


Studies on Diuretic Effect

Clinical trials have explored the use of E. arvense as a diuretic (a substance that increases urine flow).

  • A randomized, double-blind clinical trial in healthy volunteers investigated the acute diuretic effect of a standardized dried extract. The study reported that the diuretic effect was significantly stronger than that of a negative control (placebo) and comparable to the effect observed with hydrochlorothiazide (a common diuretic medication) over a short period.
  • The same research reported that the extract did not cause significant changes in the elimination of electrolytes, such as sodium and potassium, during the acute use period studied.

Studies on Bone and Connective Tissue

Traditional uses related to bone health are supported by the herb's high content of silicon, a mineral essential for bone formation and connective tissue. Research in this area is mostly preclinical, but some findings are noted:

Area of Research Key Research Finding (Preclinical) Status of Human Evidence
Osteoporosis Studies in animal models (rats with induced bone loss) suggested that E. arvense extract may contribute to the maintenance of bone mineral density and structure. Human data remains limited, with few clinical trials available to confirm these findings in patients.
Wound Healing Topical preparations containing E. arvense have been investigated, with some smaller studies examining its potential use for wound healing and its effect on conditions like brittle nail syndrome. Some small-scale, specialized trials have been conducted.

Other Areas of Investigation

Some research has explored the use of E. arvense in other conditions, including a double-blind, randomized clinical trial that assessed a standardized extract in patients with stage I systemic arterial hypertension (high blood pressure). This study reported a reduction in both systolic and diastolic blood pressure values comparable to the comparator drug used in the trial.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Equisetum arvense (FAQ)


Q: What are the most common side effects associated with Equisetum arvense use?

A: Regulatory documents state that common side effects reported with this traditional herbal medicinal product include allergic reactions and mild issues affecting the stomach and gut. These are generally reported as being minor complaints.


Q: Why do people use Equisetum arvense for hair and nail strength?

A: Official traditional use indications include its role in maintaining healthy hair, nails, and skin. This is consistent with the plant's high content of silica, a compound studied for its potential role in supporting connective tissue.


Q: Is Equisetum arvense used for skin health?

A: Yes, official information describes its use in maintaining healthy skin. It is also traditionally indicated for the supportive treatment of superficial wounds.


Q: Does Equisetum arvense interact with alcohol?

A: Concurrent use with alcohol is noted in official warnings. This is due to the potential for Equisetum arvense to impact vitamin B1 (thiamine) status, which may be worsened by regular alcohol consumption.


Q: Is it true that Equisetum arvense can reduce the body's vitamin B1 levels?

A: Official texts mention that Equisetum arvense contains an enzyme called thiaminase. This enzyme may break down vitamin B1 (thiamine), and populations with a high risk of thiamine deficiency are specifically advised to exercise caution.


Q: Is the research evidence for Equisetum arvense considered strong or limited?

A: The official assessment by the European Medicines Agency (EMA) states that the established uses of this product are based on traditional use rather than proof from extensive modern clinical trials. They note there is insufficient evidence from large clinical studies to confirm all listed uses.


Q: Are there warnings about Equisetum arvense use during pregnancy or breastfeeding?

A: Regulatory authorities do not recommend the use of Equisetum arvense during pregnancy or breastfeeding due to a lack of sufficient safety data regarding its use in these specific populations.


Q: What is the difference between Equisetum arvense and horsetail extract?

A: Horsetail herb is the common name for the Equisetum arvense plant. Extracts are one type of preparation—often liquid or dry—that is made from the dried aerial parts of the herb. Other preparations include the comminuted herb or expressed juice.


Q: Is Equisetum arvense the same thing as silica supplements?

A: Equisetum arvense is officially described as a natural source of silica (or silicon) and is used in health products for this purpose. However, it is a whole herbal product containing many components, and is not categorized as an isolated silica supplement.


Q: Can Equisetum arvense be used alongside common vitamins like C or D?

A: The primary regulatory interaction concern is related to vitamin B1 (thiamine) status. Official product listings frequently show Equisetum arvense in combination with other common vitamins like Vitamin C and Vitamin D, suggesting co-administration is standard practice.


Q: Does Equisetum arvense have a specific safety warning from health organizations?

A: Official regulatory monographs contain a dedicated section on Special Warnings and Precautions for Use. This section generally details conditions and circumstances that require consultation with a qualified healthcare practitioner.


Q: How quickly do most people report noticing effects from Equisetum arvense?

A: Official guidelines for traditional use define the typical duration of use as 2 to 4 weeks. If symptoms worsen or persist for more than 1 week of use, consultation is required. This time frame provides the necessary period before consultation is required.


Q: Is it appropriate for older adults to consider using Equisetum arvense?

A: The official posology (dosing) section of the EMA monograph includes adults and the elderly as populations for which use is traditionally indicated.


Q: Why does Equisetum arvense sometimes contain the word 'arvense'?

A: 'Arvense' is the specific species name (E. arvense L.) used in the botanical classification. It is included in official texts to ensure accurate plant identification and to distinguish this species from other, potentially toxic, related species.


Q: Are there any food or beverage restrictions mentioned when using Equisetum arvense?

A: Official warnings focus on the need to ensure appropriate fluid intake during use to support the diuretic effect. There is also a specific interaction note concerning alcohol consumption due to the risk of thiamine deficiency.


Q: What kind of allergic reactions might happen when taking Equisetum arvense?

A: Regulatory texts report the possibility of allergic reactions in sensitive individuals. These reactions may include a skin rash or a form of skin inflammation known as allergic dermatitis.


Q: What happens if someone accidentally takes too much Equisetum arvense?

A: If an amount larger than recommended is used, it may be associated with severe adverse effects. These effects can include an irregular heartbeat (heart palpitations), and the official information indicates that medical attention is required.


Q: Is Equisetum arvense related to any poisonous plants?

A: Official information notes that a related species of horsetail, Equisetum palustre (Marsh Horsetail), is considered toxic to horses and is specifically contraindicated for human use. This is why accurate identification of E. arvense is important.


Q: Does the form (capsule, tea, liquid) of Equisetum arvense affect its use?

A: Yes, official regulatory documents provide different recommended dosage regimens (posology) for various approved forms. These forms include the herbal tea (infusion or decoction), liquid extracts, and solid forms such as capsules or tablets.


Q: What are the expected benefits that studies have focused on for Equisetum arvense?

A: Traditional indications focus on its use for minor problems in the urinary tract to increase urine flow and achieve flushing. Additionally, health product listings cite its role in maintaining healthy hair, nails, and skin.


Q: Can I take Equisetum arvense if I have a potassium deficiency?

A: Official warnings state that the use of Equisetum arvense may cause the body to flush potassium out. It should therefore be used with caution or avoided by individuals with a risk of low potassium levels (hypokalemia).


Q: Does Equisetum arvense contain nicotine?

A: Official notes indicate that Equisetum arvense contains traces of nicotine. For this reason, it is advised to avoid its use if you are on nicotine replacement therapy or if you have a known nicotine allergy.


Q: What is the difference between Equisetum arvense and other Equisetum species?

A: Official warnings caution that other species of horsetail, such as Equisetum palustre, are contraindicated for human use due to toxicity. This emphasizes why official product labeling must use the correct species name, E. arvense.


Q: Has Equisetum arvense been studied for its effects on bladder support?

A: Traditional use is officially indicated for minor problems affecting the urinary tract to increase urine flow and achieve a flushing effect. The urinary tract includes the bladder and surrounding structures.


Q: Is Equisetum arvense considered a supplement or a drug by regulators?

A: Regulatory bodies classify this product differently across regions. For example, in Europe, it is classified as a traditional herbal medicinal product. In countries like Canada, it may be classified as a Natural Health Product.


Q: What does official data say about Equisetum arvense and liver health?

A: A specialized regulatory database notes that while clinically apparent liver injury appears rare with conventional doses, use is not recommended in persons with pre-existing liver disease or cirrhosis, particularly when high or long-term doses are involved.


Q: What are the main chemical components of Equisetum arvense?

A: Key components described in regulatory-cited literature include flavonoids (antioxidant compounds), flavone glycosides, silicic acid (a source of silica), and pyridine alkaloids.


Q: Is Equisetum arvense typically used as a short-term or long-term product?

A: Official guidelines for traditional use specify a course duration limit of 2 to 4 weeks. This defined limit indicates that the product is intended for short-term use.


Q: What is the source of the silica found in Equisetum arvense?

A: The high content of silica, primarily in the form of silicic acid, is an intrinsic component derived directly from the aerial parts (shoots) of the Equisetum arvense plant itself.


Q: Why do some people recommend Equisetum arvense for fluid retention?

A: The official traditional indication for use is to increase the amount of urine to achieve flushing of the urinary tract. This physiological mechanism is associated with reducing fluid volume, which is the body's natural response to fluid retention.


Q: Can Equisetum arvense cause stomach upset?

A: Regulatory documents report that mild stomach and gut complaints are a possible side effect associated with the use of this herbal product.


Q: Is Equisetum arvense classified as Generally Recognized as Safe (GRAS) in the US?

A: Equisetum arvense has been listed by the US Food and Drug Administration (FDA) as an herb of undefined safety. This classification is given when there is not enough data to determine whether it is safe or unsafe.


Q: What is the botanical family of Equisetum arvense?

A: The plant's botanical classification places it in the family Equisetaceae, which is its biological grouping.

Advertisements

How should Equisetum arvense be stored and disposed of?

How to Store and Dispose of Equisetum arvense?

The storage and disposal instructions for products containing Equisetum arvense (Horsetail Herb) are defined by regulatory documents to ensure product stability and environmental safety.


Official Storage Requirements

Condition Regulatory Mandate
Environment Store in a cool, dark place; protect from light and moisture and away from localized heat sources.
Packaging Keep the container tightly closed after use; solid forms should be kept in the original container or blister pack.
Access The product must be kept out of the sight and reach of children.

Official Disposal Instructions

Unused or expired product must be disposed of according to local regulatory guidelines. To prevent contamination, the product must not be disposed of via household wastewater or poured into the sewage system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Equisetum arvense found in:

A-Z Index: